| scholarly article | Q13442814 |
| P50 | author | Shuji Ogino | Q18055035 |
| Curtis Huttenhower | Q19397499 | ||
| Edward L. Giovannucci | Q20740896 | ||
| Charles S. Fuchs | Q88762246 | ||
| Teppei Morikawa | Q90657039 | ||
| Mai Yamauchi | Q114421478 | ||
| Paul Lochhead | Q114578193 | ||
| P2093 | author name string | Andrew T Chan | |
| P2860 | cites work | Epigenetics and colorectal cancer | Q36081553 |
| One colon lumen but two organs | Q36179345 | ||
| Molecular classification and correlates in colorectal cancer | Q36329300 | ||
| Colorectal cancers choosing sides | Q37920199 | ||
| Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location | Q37992642 | ||
| Multiple genetic alterations in distal and proximal colorectal cancer | Q41276951 | ||
| Evidence that c-myc expression defines two genetically distinct forms of colorectal adenocarcinoma | Q42373397 | ||
| Clues to the pathogenesis of familial colorectal cancer | Q42622043 | ||
| Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials | Q42849516 | ||
| Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival | Q43722687 | ||
| Colon carcinoma – Classification into right and left sided cancer or according to colonic subsite? – Analysis of 29 568 patients | Q45324117 | ||
| Tumor subsite location within the colon is prognostic for survival after colon cancer diagnosis | Q46289740 | ||
| Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer | Q46578998 | ||
| Trends in colorectal cancer incidence in Sweden 1959-93 by gender, localization, time period, and birth cohort | Q50890544 | ||
| Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer | Q52846071 | ||
| Female gender is a major determinant of changing subsite distribution of colorectal cancer with age. | Q53542828 | ||
| Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features. | Q54583151 | ||
| Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer. | Q54631097 | ||
| Trends in right and left-sided colon cancer | Q71736536 | ||
| Map of differential transcript expression in the normal human large intestine | Q80140586 | ||
| Analysis of colorectal cancer morphology in relation to sex, age, location, and family history | Q83254020 | ||
| Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis | Q22122362 | ||
| CpG Island Methylation in Colorectal Cancer: Past, Present and Future | Q24597977 | ||
| Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma | Q24603069 | ||
| Genomic analysis identifies association of Fusobacterium with colorectal carcinoma | Q24603176 | ||
| Molecular origins of cancer: Molecular basis of colorectal cancer | Q24617331 | ||
| Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field | Q24620628 | ||
| Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology | Q24622814 | ||
| Microsatellite instability in colorectal cancer | Q24627393 | ||
| Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum | Q28262150 | ||
| CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer | Q29614277 | ||
| Genetic instability in colorectal cancers | Q29618711 | ||
| Microsatellite instability in cancer of the proximal colon | Q29620692 | ||
| Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample | Q33383866 | ||
| DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer. | Q33517453 | ||
| Body size, physical activity and risk of colorectal cancer with or without the CpG island methylator phenotype (CIMP). | Q33869180 | ||
| Trends in colorectal cancer incidence: a period and birth-cohort analysis in a well-defined French population | Q33947174 | ||
| Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer | Q33954716 | ||
| Mortality by Stage for Right- Versus Left-Sided Colon Cancer: Analysis of Surveillance, Epidemiology, and End Results–Medicare Data | Q34039306 | ||
| Cigarette smoking and colorectal cancer risk by molecularly defined subtypes | Q34042268 | ||
| A metaproteomic approach to study human-microbial ecosystems at the mucosal luminal interface. | Q34087598 | ||
| Bacterial biogeography of the human digestive tract | Q34166642 | ||
| The CpG island methylator phenotype in colorectal cancer: progress and problems | Q34230273 | ||
| Trends in Colorectal Cancer Incidence Rates in the United States by Tumor Location and Stage, 1992–2008 | Q34244636 | ||
| Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancer | Q34358286 | ||
| Colorectal cancer molecular biology moves into clinical practice | Q34425013 | ||
| Sex disparities in colorectal cancer incidence by anatomic subsite, race and age | Q34542974 | ||
| Meat consumption and risk of colorectal cancer: a meta-analysis of prospective studies | Q34571139 | ||
| Personalized Colon Cancer Care in 2010 | Q34731381 | ||
| Are there two sides to colorectal cancer? | Q34822109 | ||
| Cancer immunology--analysis of host and tumor factors for personalized medicine | Q35583180 | ||
| Two colons-two cancers: paradigm shift and clinical implications | Q35964258 | ||
| Different age and sex relationship for cancer of subsites of the large bowel | Q35992046 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 794-797 | |
| P577 | publication date | 2012-04-05 | |
| P1433 | published in | Gut | Q5621669 |
| P1476 | title | Colorectal cancer: a tale of two sides or a continuum? | |
| P478 | volume | 61 |
| Q36245897 | A Comprehensive Model of Colorectal Cancer by Risk Factor Status and Subsite Using Data From the Nurses' Health Study |
| Q59237862 | A Mobile and Evolving Tool to Predict Colorectal Cancer Survivability |
| Q90633417 | A longitudinal study of prediagnostic metabolic biomarkers and the risk of molecular subtypes of colorectal cancer |
| Q36854546 | A nationwide Danish cohort study challenging the categorisation into right-sided and left-sided colon cancer |
| Q37003013 | A pilot study comparing protein expression in different segments of the normal colon and rectum and in normal colon versus adenoma in patients with Lynch syndrome |
| Q41686298 | A prognostic analysis of 895 cases of stage III colon cancer in different colon subsites |
| Q36974863 | A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification |
| Q33611163 | Age-specific prevalence of serrated lesions and their subtypes by screening colonoscopy: a retrospective study |
| Q37179522 | Anatomic subsite of primary colorectal cancer and subsequent risk and distribution of second cancers |
| Q55379897 | Ancient Thali Diet: Gut Microbiota, Immunity, and Health. |
| Q38036541 | Aspirin as adjuvant therapy for colorectal cancer—reinterpreting paradigms |
| Q37094281 | Aspirin use and risk of colorectal cancer according to BRAF mutation status |
| Q28277824 | Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival |
| Q39921888 | Association between adenoma location and risk of recurrence |
| Q48010330 | Association between clinicopathological characteristics and RAS mutation in colorectal cancer |
| Q92126721 | Association between local immune cell infiltration, mismatch repair status and systemic inflammatory response in colorectal cancer |
| Q39703372 | Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer. |
| Q41372623 | Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway |
| Q53048661 | Associations between birth weight and colon and rectal cancer risk in adulthood |
| Q44266117 | Authors' reply: Meat subtypes and their association with colorectal cancer: Systematic review and meta-analysis |
| Q36306276 | BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristics |
| Q41056167 | BRAF mutation-specific promoter methylation of FOX genes in colorectal cancer |
| Q40084852 | Childhood body mass index and height in relation to site-specific risks of colorectal cancers in adult life. |
| Q48374992 | Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers. |
| Q39184305 | Colon cancer subtypes: concordance, effect on survival and selection of the most representative preclinical models. |
| Q38652194 | Colorectal Cancer Subtypes: Developmental Origin and Microenvironmental Regulation |
| Q38699118 | Colorectal cancer surgery in the very elderly patient: a systematic review of laparoscopic versus open colorectal resection. |
| Q53253114 | Colorectal cancer: dichotomous or continuum model? Perhaps, a combination of both: Table 1 |
| Q55411157 | Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells. |
| Q47149577 | Combination of primary tumor location and mismatch repair status guides adjuvant chemotherapy in stage II colon cancer |
| Q36195885 | Commentary: Lifestyle factors and colorectal cancer microsatellite instability--molecular pathological epidemiology science, based on unique tumour principle |
| Q41230971 | Comparison of biomarker expression between proximal and distal colorectal adenomas: The Tennessee-Indiana Adenoma Recurrence Study |
| Q34598203 | Computational analysis of KRAS mutations: implications for different effects on the KRAS p.G12D and p.G13D mutations |
| Q59237878 | Developing an Individualized Survival Prediction Model for Colon Cancer |
| Q59237802 | Developing an Individualized Survival Prediction Model for Rectal Cancer |
| Q36001973 | Different clinicopathologic features and favorable outcomes of patients with stage III left-sided colon cancer |
| Q27011884 | Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology |
| Q47124374 | Does primary tumor location impact the prognosis of colorectal liver metastases patients after microwave ablation? - Lessons from 10 years' experience |
| Q34487177 | Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers |
| Q37061792 | Epigenetics and colorectal cancer pathogenesis |
| Q35037282 | Estrogen receptors and their implications in colorectal carcinogenesis |
| Q26852716 | Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression |
| Q52666988 | FOLFOX plus anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) is an effective first-line treatment for patients with RAS-wild left-sided metastatic colorectal cancer: A meta-analysis |
| Q36954024 | FOXP3 and CEACAM6 expression and T cell infiltration in the occurrence and development of colon cancer |
| Q53639784 | Familial colorectal cancer risk by subsite of primary cancer: a population-based study in Utah |
| Q38232753 | Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis |
| Q35956384 | Fusobacterium nucleatum and T Cells in Colorectal Carcinoma |
| Q39217446 | Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location |
| Q40603067 | Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis |
| Q37440936 | Genome-wide analysis of the rat colon reveals proximal-distal differences in histone modifications and proto-oncogene expression |
| Q36405847 | Habitual intake of flavonoid subclasses and risk of colorectal cancer in 2 large prospective cohorts |
| Q37696586 | Heterogeneity of colorectal cancer risk by tumour characteristics: Large prospective study of UK women |
| Q35677169 | High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort |
| Q38859851 | High expression of CD39/ENTPD1 in malignant epithelial cells of human rectal adenocarcinoma |
| Q27002388 | Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis |
| Q90327670 | Increased expression of antisense lncRNA SPINT1-AS1 predicts a poor prognosis in colorectal cancer and is negatively correlated with its sense transcript |
| Q34656265 | Increased risk of colorectal cancer in type 2 diabetes is independent of diet quality |
| Q55315465 | Individualized predictive signatures for 5-fluorouracil-based chemotherapy in right- and left-sided colon cancer. |
| Q35130874 | Influence of microsatellite instability and KRAS and BRAF mutations on lymph node harvest in stage I-III colon cancers |
| Q62494554 | Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology |
| Q53601791 | Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology. |
| Q50043586 | Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine |
| Q24289208 | Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science |
| Q34487770 | Laser microdissection and two-dimensional difference gel electrophoresis reveal proteomic intra-tumor heterogeneity in colorectal cancer |
| Q34038277 | Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial |
| Q36688767 | Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision. |
| Q37100729 | Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer |
| Q44981365 | MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions. |
| Q53688571 | Microbiota and metabolic diseases. |
| Q37075412 | Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication |
| Q38363519 | Microsatellite instability: an update |
| Q40120812 | Molecular classification of colorectal cancer: Current perspectives and controversies |
| Q24289344 | Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease |
| Q30244608 | Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis. |
| Q44891666 | Molecular pathological findings of Merkel cell polyomavirus in lung cancer: a possible etiopathogenetic link? |
| Q26785725 | Molecular phenotypes of colorectal cancer and potential clinical applications |
| Q34674089 | Pattern of distant metastases in colorectal cancer: a SEER based study |
| Q37172368 | Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia. |
| Q36926941 | Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer |
| Q34502713 | Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status. |
| Q37360360 | Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial. |
| Q92440787 | Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score |
| Q34475686 | Proceedings of the second international molecular pathological epidemiology (MPE) meeting |
| Q38828841 | Processed Meat and Colorectal Cancer Risk: A Pooled Analysis of Three Italian Case-Control Studies |
| Q90254924 | Prognostic Implications of Extranodal Extension in Relation to Colorectal Cancer Location |
| Q37111201 | Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location |
| Q30248900 | Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis |
| Q35137525 | Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma |
| Q34016833 | Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions |
| Q33812820 | Progressive proximal-to-distal reduction in expression of the tight junction complex in colonic epithelium of virally-suppressed HIV+ individuals. |
| Q36675320 | Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status. |
| Q36535688 | Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level |
| Q26771416 | Red Meat and Colorectal Cancer |
| Q40360515 | Relationship between drugs affecting the renin-angiotensin system and colorectal cancer: The MCC-Spain study |
| Q91937575 | Relationship of telomere length in colorectal cancer patients with cancer phenotype and patient prognosis |
| Q36968401 | Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine |
| Q38322257 | Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much? |
| Q64927739 | Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection. |
| Q102220443 | Rising incidence of early-onset colorectal cancer - a call to action |
| Q40795018 | Role of Fusobacteria in the serrated pathway of colorectal carcinogenesis |
| Q34266707 | Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives |
| Q66475538 | Rotating night shift work and colorectal cancer risk in the nurses' health studies |
| Q26827208 | Serrated lesions of the colorectum: review and recommendations from an expert panel |
| Q38473801 | Serrated neoplasia-role in colorectal carcinogenesis and clinical implications |
| Q55497334 | Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer. |
| Q47117539 | Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie). |
| Q36108299 | Somatic gene mutations in African Americans may predict worse outcomes in colorectal cancer |
| Q91907015 | Systemic and local inflammation in colorectal cancer |
| Q36510909 | The Critical Role of Dysregulated FOXM1–PLAUR Signaling in Human Colon Cancer Progression and Metastasis |
| Q34450525 | The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer |
| Q41441746 | The expression and clinical significance of CD73 molecule in human rectal adenocarcinoma |
| Q37288532 | The homeobox gene MEIS1 is methylated in BRAF (p.V600E) mutated colon tumors |
| Q87084008 | The molecular genetics of colorectal cancer |
| Q57602278 | The presence of clustered circulating tumor cells (CTCs) and circulating cytokines define an aggressive phenotype in metastatic colorectal cancer |
| Q37688202 | Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival |
| Q34169734 | Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis |
| Q40244514 | Tumor SQSTM1 (p62) expression and T cells in colorectal cancer. |
| Q33828917 | Tumor location as a novel high risk parameter for stage II colorectal cancers |
| Q40746149 | Tumour CD274 (PD-L1) expression and T cells in colorectal cancer. |
Search more.